Zhi Yi Fang

Zhi Yi Fang

Auto-generated profile, based on publicly available information

Zhi Yi Fang

Dept. of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
AZAmanda M. Zacharias
Amanda M. Zacharias
COCiara D. O’cOnnor
Ciara D. O’cOnnor
Danai Georgia TopouzaDanai Georgia Topouza
Danai Georgia Topouza
ZFZhi Yi Fang
Zhi Yi Fang
HGHelia Ghazinejad
Helia Ghazinejad
NGNader Ghasemlou
Nader Ghasemlou
Biological rhythms control gene expression, but effects on central nervous system (CNS) cells and structures remain poorly defined. While circadian (24-hour) rhythms are most studied, many genes have periods of greater and less than 24-hours; these fluctuations can be both site- and cell-specific. Identifying patterns of gene rhythmicity across the CNS is necessary for both the study of chronobiology and to make sense of data obtained in the laboratory. We now identify cycling mRNAs, miRNAs, gene networks and mRNA-miRNA co-expression pairs in the cortex, hypothalamus, and corpus striatum of male C57BL/6J mice using high-dimensional datasets. A searchable catalogue (https://www.ghasemloulab.ca/chronoCNS) helps refine the analysis of cellular and molecular rhythmicity across the CNS (using the liver as a control). Immunofluorescence confirms the rhythmicity of key targets across cells in these structures, with strong cycling signatures in resting oligodendrocytes. Our study sheds light on the contribution of diurnal, ultradian, and infradian rhythms and mRNA-miRNA interactions to CNS function.

13 September 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAmanda M. Zacharias
Amanda M. Zacharias
COCiara D. O’connor
Ciara D. O’connor
Danai Georgia TopouzaDanai Georgia Topouza
Danai Georgia Topouza
ZFZhi Yi Fang
Zhi Yi Fang
HGHelia Ghazinejad
Helia Ghazinejad
NGNader Ghasemlou
Nader Ghasemlou
Biological rhythms control gene expression, but effects on central nervous system (CNS) cells and structures remain undefined. While circadian (24-hour) rhythms are most studied, many genes have periods of greater and less than 24-hours; these fluctuations can be both site- and cell-specific. Identifying patterns of gene rhythmicity across the CNS is necessary for both the study of chronobiology and to make sense of data obtained in the laboratory. We now identify cycling mRNAs, miRNAs, gene networks and novel mRNA-miRNA co-expression pairs in the cortex, hypothalamus, and corpus striatum using high-dimensional datasets. A searchable catalogue (https://www.ghasemloulab.ca/chronoCNS) was created to help refine the analysis of cellular/molecular rhythmicity across the CNS. Immunofluorescence was also used to confirm the rhythmicity of key targets across cells in these structures, with strong cycling signatures in resting oligodendrocytes. Our study sheds light on the contribution of circadian, ultradian, and infradian rhythms and mRNA-miRNA interactions to CNS function.

30 July 2025 in Research Square
Verified
Preprint
Open access
PDF file
QDQing Ling Duan
Qing Ling Duan
ZFZhi Yi Fang
Zhi Yi Fang
SSSara Stickley
Sara Stickley
JCJihoon Choi
Jihoon Choi
EGElizabeth George
Elizabeth George
MAMeghan Azad
Meghan Azad
Although human milk (HM) is known to benefit infant health, how its many bioactive components (e.g., microbiota (HMM), oligosaccharides (HMOs), and fatty acids (HMFAs)) influence the risk of childhood atopy remains poorly understood. Our study integrated polygenic risk scores (PRS) of nursing infants with human milk components (HMCs) from their mothers in the CHILD Cohort Study to explore potential gene-milk interactions associated with childhood atopy at ages 1-5. For example, among infants with high PRS, exposure to increased abundance of the microbe Abiotrophia was associated with increased childhood atopy prevalence. Moreover, network analyses combining all HMCs revealed that a module of correlated HMM and HMOs including Abiotrophia and 3-fucosyllactose, respectively, was associated with reduced childhood atopy prevalence. Another network module of correlated HMCs (e.g., Bifidobacterium longum, 2'-fucosyllactose, and eicosapentaenoic acid) was associated with reduced childhood atopy prevalence among infants with high PRS. Finally, a gradient-boosting model (GBM) integrating HMCs and infant PRS predicted childhood atopy with an area under the curve (AUC) of 0.78, outperforming GBMs using any individual HMC or infant PRS alone (AUC range: 0.48-0.63). Our study reports both main and interaction effects of HMCs and infant PRS on childhood atopy. An improved understanding of how early-life exposures such as HMCs impact the health of children differently depending on their genomic profiles may facilitate the development of personalized intervention strategies to reduce the burden of these health outcomes during childhood.

13 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZFZhi Yi Fang
Zhi Yi Fang
SSSara A. Stickley
Sara A. Stickley
JCJihoon Choi
Jihoon Choi
EGElizabeth George
Elizabeth George
JSJoel Sagman
Joel Sagman
QDQing Ling Duan
Qing Ling Duan
Background: Although human milk (HM) confers important health benefits, how bioactive milk components (e.g., microbiota, oligosaccharides, and fatty acids) interact with infant genetics to influence childhood atopy remains poorly understood. Objective: We investigated interactions between infant genomic susceptibility and exposure to maternal human milk components (HMCs) and assessed whether integrating these genetic and milk features improves prediction of childhood atopy. Methods: Leveraging infant genomic and maternal HMC data from the CHILD Cohort Study, we conducted gene-milk interaction analysis using linear regression models that integrated polygenic risk scores (PRS) of nursing infants with multiple HMC types. Gradient-boosting machines (GBMs) were used to evaluate predictive performance of HMCs and infant PRS for childhood atopy. Results: Childhood atopy was associated with interactions between infant genomics (e.g., PRS associated with atopy) and exposure to specific human milk microbes (e.g., Abiotrophia , P Bonf =0.005, β=0.29), as well as networks of co-occurring HMCs (e.g., a module containing Bifidobacterium longum , 2’-fucosyllactose, and eicosapentaenoic acid, P=0.009, β=-12.3). A GBM integrating HMCs and infant PRS achieved the highest predictive performance for childhood atopy with an area under the curve (AUC) of 0.78, outperforming models based on individual HMC types or PRS alone (AUC range: 0.54-0.63). Conclusion: Integration of maternal HMC exposures with infant genomics reveals interaction effects that contribute to prediction of childhood atopy. Understanding how early-life exposures such as HMCs impact the health of children differently depending on their genomic profiles may facilitate the development of personalized intervention strategies to reduce the burden of these health outcomes during childhood. Key messages: Interactions between infant polygenic risk and exposure to human milk components are associated with childhood atopy. Networks of co-occurring human milk microbiota, oligosaccharides, and fatty acids may influence childhood atopy, with effects varying by infant genomic susceptibility. Integration of human milk components with infant genomics improves prediction of childhood atopy compared with individual milk components or genomics alone. Capsule Summary: This study demonstrates that interactions between infant polygenic risk and maternal milk components improve prediction of childhood atopy, highlighting opportunities for personalized early-life prevention strategies.